Tables at a glance

Table 1

Table 2

Table 3

Table 4

Table 1

parameters	Time	min	max	mean	SD
Age (Yrs.)		65	92	73/38	98/6
Systolic BP (mmHg)	Pre	115	155	134/85	96/8
	Post	100	150	122/16	8/9
	Δ	0	50	12/69	71/9
Diastolic BP(mmHg)	Pre	65	95	79/41	19/5
	Post	60	90	74/66	78/5
	Δ	0	20	4/75	84/4
HR (Per min)	Pre	48	85	71/45	39/7
	Post	52	90	77/05	89/6
	Δ	0	32	5/6	92/4

*BP: Blood Pressure, HR: Heart Rate
Table 1: Demographic and clinical characteristics of patients before and after intervention

Table 2

Parameters	Time	Intervention	Mean ± SD	P-value( A Vs C)	P-value( B Vs C)	P-value (A Vs B)

Systolic BP (mmHg)	Pre	ondansetron	134/45 ±9/84	0/68	0/84	0/84

		dexamethasone	134/87 ±9/3


		Control	135/25 ±7/84
	Post	ondansetron	124/5 ±9/52	0/001	0/001	0/001

		dexamethasone	124/62 ± 8/5


		Control	117/37 ±9/73
Diastolic BP(mmHg)	Pre	ondansetron	78/87 ±5/82	0/57	0/73	0/43

		dexamethasone	79/87 ±5/6


		Control	79/5 ±4/05
	Post	ondansetron	74/87 ±5/6	0/03	0/001	0/15

		dexamethasone	76/75±6/05


		Control	72/37±4/93
HR (Per min)	Pre	ondansetron	75/42 ±7/84	0/06	0/59	0/21


		dexamethasone	77/5 ±7/07


		Control	78/25 ±5/73
	Post	ondansetron	70/97 ±8/51	0/61	0/04	0/21

		dexamethasone	73/25 ±7/55


		Control	70/15 ±8/51

Table 2: Investigating the difference between intervention groups in terms of blood pressure and heart rate factors before and after drug administration

Table 3

Parameters	Intervention	Mean ± SD	P-value( A Vs C)	P-value( B Vs C)	P-value (A Vs B)
Δ Systolic BP (mmHg)	ondansetron	9/95 ±8/04	0/001	0/001	0/86

	dexamethasone	10/25 ±7/15


	Control	17/87 ±11/42
Δ Diastolic BP(mmHg)	ondansetron	4± 3/43	0/005	0/005	0/29


	dexamethasone	3/12 ±4.03

	Control	7/12±5/87
HR (Per min) Δ	ondansetron	4/45±3/66	0/005	0/001	0/79

	dexamethasone	4/25±3/31

	Control	8/1 ±6/31

Table 3: Examining the difference between groups from the perspective of differences in blood pressure and heart rate factors before and after intervention

Table 4

Parameters	Intervention	N (%)	P-value( A Vs C)	P-value( B Vs c)	P-value (A Vs B)


Atropine	ondansetron	1(2.5)	0/02	0/02	0/99


	dexamethasone	1(2.5)

	Control	8(20)
Ephedrine	ondansetron	1(2.5)	0/006	0/006	0/69



	dexamethasone	1(2.5)


	Control	10(25)

Table 4: Examining the difference between the intervention groups in terms of atropine and ephedrine administration